BioAtla, Inc. (BCAB)
OTCMKTS · Delayed Price · Currency is USD
2.000
-0.090 (-4.31%)
At close: Nov 6, 2026
BioAtla Market Cap
BioAtla has a market cap or net worth of $3.33 million as of November 6, 2026. It is the 46,389th most valuable company in the world and the 6,146th biggest in the United States. Its market cap has decreased by 91.20% in one year.
Market Cap
3.33M
Enterprise Value
7.65M
Revenue
8.50M
Global Rank
Country Rank
#6,146 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since December 16, 2020, BioAtla's market cap has decreased from 9.78B to 3.33M, a decrease of -99.97%. That is a compound annual growth rate of -74.20%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 3.33M | -90.06% |
| Dec 31, 2025 | 33.51M | -2.30% |
| Dec 31, 2024 | 34.30M | -70.91% |
| Dec 29, 2023 | 117.92M | -86.61% |
| Dec 30, 2022 | 880.59M | -59.20% |
| Dec 31, 2021 | 2.16B | -40.57% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Zenith Capital | 4.83M |
| Reviva Pharmaceuticals Holdings | 4.46M |
| LianMedical | 4.20M |
| Orgenesis | 3.92M |
| Abpro Holdings | 3.40M |
| Institute of Biomedical Research | 3.30M |
| VitaSpring Biomedical | 3.21M |
| NDT Pharmaceuticals | 2.87M |